News Major shareholder announcement – BlackRock, Inc. Staff September 11, 2023 Iframe sync Post Navigation Previous Invivyd Announces Dosing of First Participant in CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of Symptomatic COVID-19 Next Scinai Immunotherapeutics Ltd. to participate this week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in Boston More Stories Healthcare News Custom Health Enters into Definitive Agreement to Complete Business Combination with Queue Ventures Staff May 30, 2025 Healthcare News Pharmaceutical Vaniam Group™ Introduces Vaniam Intelligence™: Purpose-Built AI, Guided by Human Insight Staff May 30, 2025 Cancer Healthcare News Patient Care Pharmaceutical Provider Network Holdings Appoints Dr. Edith A. Perez, M.D. as Chief Medical Officer of Cornerstone Specialty Network Staff May 30, 2025
